SynCo’s multi-purpose GMP facilities offer manufacturing capabilities for microbial based biopharmaceuticals (such as proteins and vaccines) for worldwide supply according to the highest quality standards.
SynCo is world leader in Live Microbial projects, which refers to products containing whole, live microorganisms, such as bacteria or yeast with an intended therapeutic or preventive effect in humans.
SynCo has broad experience in aseptic filling and lyophilization of biotherapeutics and offers a ‘one stop shop’, in a full state-of-the-art fill and finish facility, located in the same building where the drug substance manufacturing occurs.
Microbiome Drug Development Summit Europe
January 26 – 27, 2017 Renaissance La Defense Hotel, Paris, France
For more information visit the Microbiome Drug Development Summit page, click here
SynCo Bio Partners
All rights reserved. © 2016 | Terms | Privacy